Intensive Medicines Monitoring Project of Palonosetron Hydrochloride Capsules (Ruo Shan®)
NCT03148704 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2017-05-11
Summary
Observe palonosetron hydrochloride capsules'(Ruo Shan®) safety and efficacy information in the real world using.
Conditions
- Palonosetron
Interventions
- DRUG
-
palonosetron hydrochloride capsules
Collect all the patients' safty and efficacy data as long as they use palonosetron hydrochloride capsules(Ruo Shan®) .Specific methods of using the drugs are not limited .
Sponsors & Collaborators
-
Cttq
lead INDUSTRY
Principal Investigators
-
qin shu kui · The 81st Hostital of PLA
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-08
- Primary Completion
- 2018-03-08
- Completion
- 2018-06-08
Countries
- China
Study Locations
More Related Trials
-
Investigate Absorption, Metabolism, Excretion, and Mass Balance of Pacritinib
NCT02803762 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of SHEN26 Capsule in Healthy Participants
NCT05504746 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Characterize the Absorption, Metabolism, and Excretion of 14C-JNJ-53718678 After a Single Oral Dose in Healthy Male Participants
NCT03002779 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers
NCT01537172 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy Volunteers
NCT02647697 ·Status: COMPLETED ·Phase: PHASE1
-
The Absorption, Metabolism and Excretion of [14C]APG-2575 in Healthy Subjects
NCT05517616 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants
NCT05475834 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Ascending and Food Effect Study of RP7214, a DHODH Inhibitor in Healthy Adult Subjects
NCT04680429 ·Status: COMPLETED ·Phase: PHASE1
-
A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjects
NCT06669429 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Safety, Pharmacokinetics (Including Food Effect) And Pharmacodynamics of RO5545965 in Healthy Volunteers
NCT01711801 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RSS0343 Tablets in Healthy Subjects After Single and Multiple Oral Administration and the Effect of Food on the Pharmacokinetics of RSS0343
NCT07101965 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of RO6806127 in Healthy Male Volunteers
NCT02196636 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects
NCT01590901 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.
NCT06346925 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study to Assess Bioavailability of GLPG1690 Given as Oral Capsule or Tablet
NCT03143712 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance Study of KBP-5074 in Healthy Male Subjects
NCT04634812 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Ascending Dose and Food Effect PK Study in Healthy Adult and Elderly Subjects
NCT03668314 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy Participants
NCT06506175 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of TAK-279 in Healthy Chinese Adults
NCT06111547 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Phase 1 Study of CP1050
NCT03468413 ·Status: UNKNOWN ·Phase: PHASE1
-
Study on the Mass Balance of [14C]HRS-8427 for Injection in Healthy Chinese Subjects
NCT07049562 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male Participants
NCT02448004 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Characteristics of HHT120 in Healthy Subjects
NCT05414734 ·Status: WITHDRAWN ·Phase: PHASE1
-
Mass Balance Recovery, Metabolite Profile, and Metabolite Identification of [14C]-Paxalisib in Healthy Male Subjects
NCT05012670 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405
NCT02846181 ·Status: COMPLETED ·Phase: PHASE1